Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$34.1K Sell
320
-4
-1% -$484 ﹤0.01% 1500
2026
Q1
$53K Sell
324
-16
-5% -$2.46K ﹤0.01% 1302
2025
Q4
$59.2K Sell
340
-224
-40% -$40.9K ﹤0.01% 1291
2025
Q3
$81.2K Hold
564
﹤0.01% 1166
2025
Q2
$56.8K Sell
564
-342
-38% -$26.1K ﹤0.01% 1367
2025
Q1
$69.1K Buy
906
+75
+9% +$5.74K ﹤0.01% 1170
2024
Q4
$57.4K Sell
831
-1,128
-58% -$81.2K ﹤0.01% 1224
2024
Q3
$131K Buy
1,959
+1,879
+2,349% +$139K ﹤0.01% 1074
2024
Q2
$2.17K Buy
+80
New +$3.1K ﹤0.01% 2425
2024
Q1
Sell
-38
Closed -$1K 2455
2023
Q4
$1K Buy
+38
New +$985 ﹤0.01% 2342
2023
Q3
Sell
-8
Closed 2157
2023
Q2
$0 Buy
+8
New +$152 ﹤0.01% 2276
2022
Q4
Sell
-30
Closed -$1K 2345
2022
Q3
$1K Buy
+30
New +$719 ﹤0.01% 1936

Other funds holding INSM

Blue Trust Inc's INSM Position: Q2 2026 in Review

Blue Trust Inc reduced its Insmed (INSM) stake by 1.2% in Q2 2026, selling an estimated $484 and leaving 320 shares worth $34.1K. The position accounts for ﹤0.01% of the portfolio, ranked #1500.

Blue Trust Inc first reported a position in INSM in Q3 2022 and has held it in 12 quarters since. The position peaked at $131K in Q3 2024. 665 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • Blue Trust Inc held 320 shares of Insmed worth $34.1K as of Q2 2026.
  • Blue Trust Inc sold 4 Insmed shares in Q2 2026, an estimated $484.
  • Insmed made up ﹤0.01% of Blue Trust Inc's portfolio in Q2 2026, its #1500 holding.
  • Blue Trust Inc first reported a position in Insmed in Q3 2022 and has held it in 12 quarters since.
  • Blue Trust Inc's Insmed position peaked at $131K in Q3 2024.
  • 665 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Blue Trust Inc's 13F filing for Q2 2026, filed 21 Jul 2026.